The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Monuril 3 g granules for oral solution

Lexon Pharmaceuticals (Ireland) LimitedPPA23176/044/001

Main Information

Trade NameMonuril 3 g granules for oral solution
Active SubstancesFosfomycin
Dosage FormGranules for oral solution
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/044/001

Group Information

ATC CodeJ01XX Other antibacterials
J01XX01 fosfomycin


License statusAuthorised
Licence Issued24/06/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back